EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS165-06412 
Organism
Homo sapiens 
Tissue/cell
Ramos 
Coordinate
chr17:76711180-76713010 
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
GLI2MA0734.2chr17:76711275-76711290AGACCACCCACGAGG+7.15
Number of super-enhancer constituents: 33             
IDCoordinateTissue/cell
SE_03593chr17:76711023-76712412Brain_Angular_Gyrus
SE_03593chr17:76712585-76716199Brain_Angular_Gyrus
SE_04177chr17:76710362-76716568Brain_Anterior_Caudate
SE_05030chr17:76709033-76722335Brain_Cingulate_Gyrus
SE_06197chr17:76709480-76716750Brain_Hippocampus_Middle
SE_07013chr17:76709128-76722223Brain_Hippocampus_Middle_150
SE_08280chr17:76709155-76716729Brain_Inferior_Temporal_Lobe
SE_09291chr17:76711164-76712866CD14
SE_10232chr17:76710234-76716463CD19_Primary
SE_10917chr17:76699585-76716888CD20
SE_14447chr17:76710268-76711913CD4_Memory_Primary_7pool
SE_16882chr17:76711114-76712183CD4p_CD225int_CD127p_Tmem
SE_17330chr17:76710288-76716652CD4p_CD25-_CD45RAp_Naive
SE_17789chr17:76710408-76716366CD4p_CD25-_CD45ROp_Memory
SE_18275chr17:76708858-76756450CD4p_CD25-_Il17-_PMAstim_Th
SE_19133chr17:76710328-76716614CD4p_CD25-_Il17p_PMAstim_Th17
SE_20047chr17:76710271-76713495CD56
SE_22344chr17:76709216-76716514CD8_primiary
SE_26201chr17:76711511-76713321Duodenum_Smooth_Muscle
SE_32461chr17:76709187-76716237GM12878
SE_39457chr17:76710273-76715896Jurkat
SE_43543chr17:76711343-76716562MM1S
SE_49999chr17:76711125-76716429RPMI-8402
SE_50271chr17:76712792-76715583Sigmoid_Colon
SE_52658chr17:76712722-76715493Small_Intestine
SE_53636chr17:76711249-76712312Spleen
SE_59073chr17:76687338-76733905Ly3
SE_60415chr17:76679151-76756346DHL6
SE_60995chr17:76690240-76779668HBL1
SE_61668chr17:76693174-76787177Toledo
SE_62236chr17:76690401-76817069Tonsil
SE_66337chr17:76710273-76715896Jurkat
SE_67253chr17:76711343-76716562MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr177671128376712268
Enhancer Sequence
AATCCCACAG AGAAATTCTC ATAGGAAAAA TTCAGAAGTT CCAGGAATAA AGACGATCCT 60
AAAACCTCCA CAGAGGTTAA GGAGAGTGAT TAATCAGACC ACCCACGAGG GAAGATCTCG 120
CTGGTGTCAG TATAAGAGCC CGCACACTAA AGATAGCGCA GTGGAACTTT CAAAATTCTA 180
AATGAAAATT ATCTGAACCC CAAATTCTCA GTCAAGTAGG AGGGTAAAAC AGACTCATTT 240
CAGATACATA AGGATCAGAA AGTTTGTCTT CTGTGCACCC CTTCTGAAGA AGCTACTTCA 300
GGAGCAAGAT GTGGATCAAG GAACGGGACT GACTCAGGAG CCTGAGGACA GCAAGCGCCA 360
TCAACTGTGA TGGCCAACAG CCACCAGACC GGGTCAGAGC AGGAAGCCAA AGGGCTGCCA 420
GAGGAATGCC ATCAGAAAGA ATGAAATCAG ACTCGAAACC AGAGAATGAA GGAGAAAGCA 480
GCTGAGAAAA CTGTGTGATA CCAACAGGCA TCATTCGGTT TCCTCTCAAG AGAATAAAAA 540
GGACTGGGCA ACAGGAAAAA CTCAACTACA GGAAATCACA GAAGAAATGA AACATGCCCC 600
CCGAGTGGTG TCCTCTGGGC CATCAGGGAC GCCAGGAACA GCTCCCTTTG AGTGGGCACC 660
TGGCTCTACG GTGAGTGGTA TCTACATTCC TGTCATGGTG CTGGTCGCTG GTAGTTAACT 720
TACAGAATCA CCCTGTAGAC AAAGCATGAA AGACCAACCC AGGCTGGAGA AGCAAAGCTA 780
TCTGTTACCA AGGTGAAGGA AGAGCTGACC AAAGTTTGAG GGAAGCAAAG TGGAGAGGGC 840
AGCAGGGTCC CAAATGGTCC CCACAGCTTC CTCCTACAAC ACTAGAGACC AGAGGCATGG 900
ATAAGGATCA TGAACAAGAA ACCCACGCTG TAAATATGCC AAAGGTAAAA ATCCAGGAAC 960
TGAAAATTGT GATCAACTAC CAAAAATGGA CAGTGAGAGA AGGAAGGAAG AGAATGGTGT 1020
GAGCTGCATC CTCATCCATC ATAGGCAGAA GGCAGGAGAT AACCTTTGAT CTTGACAAAA 1080
TAATCACCAA TTTAAGAACT TGGCAGCACC CACTAGAAGA CCTAAAAGCA GAAAAAAGTG 1140
AATTAATAGT GGCTGCTTTG GGGAGTGGGT CTGGGAATAG AGAGACAGGA CATATAAGCC 1200
CCTGAATACT TGCTTTAAAA TACATATATA TATGTACTAT GACAATTTGA AAACAAAAGA 1260
CTAAAAATGT ACAACTATGG TCACTAGAAA AGATAGCCCT TCTGTGTCCT TGGAGTCAGA 1320
CAGAAAACGC TTCTGGCCAA TTTGTAGCTA GAATAAATAA GACATTTATC TACATTTATT 1380
TTGATCCAAT CTCCTGACAT TTGCCACATG ACTGCTAAAT TACTTCTCCA TTCCATACTT 1440
ACTAACTTTA AATCATAATG CTGCTCCCCT TCTGGCTCAA CCAATCATTC AAGAACTTTA 1500
TTTTAAAAAG CTGAACTACA CCTCATTTTT CTAGTGGAAT TTTATTCTGA GATGAGGCAA 1560
AATCTAATAT TTTAATAAGT ATTTTCCTCT GCATAAACTT AACAATGCAA CATCAAATCT 1620
TTAATTCAAG CCTTCATTCT CATGCTGCCC CGGACAGAAA AAACATCCAA AAACAAAATG 1680
CTTAATTTCA TTTAGCAGCA TGAAGAATCA ACACTATTGC TGGAGAGCTG AGGTGTGATT 1740
GATTCCTACA GTCTTGGCTA GTGTCTTCAG GACACTGCGA AGGCCACAGC TGGAACAAGA 1800
AAGGTGGTGG TCAGAAATAC CCATGTCTAC 1830